THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025

Shares 14,647 Value ($000) $131 Avg Close $9.31 Range $8.35 - $10.90

Q3 2024

Shares 12,642 Value ($000) $102 Avg Close $8.66 Range $7.44 - $10.42

Q2 2024

Shares 34,336 Value ($000) $291 Avg Close $9.03 Range $8.13 - $10.44

Q4 2022

Shares 11,261 Value ($000) $126 Avg Close $10.51 Range $9.56 - $11.83

Period	Shares	Value ($000)	Average Close	Price Range
Q1 2025	14,647	$131	$9.31	$8.35 - $10.90
Q3 2024	12,642	$102	$8.66	$7.44 - $10.42
Q2 2024	34,336	$291	$9.03	$8.13 - $10.44
Q4 2022	11,261	$126	$10.51	$9.56 - $11.83